 Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neu ... ...
|
 When it comes to the mechanics of the human immune system, we are all more alike than previously thought, according to a new study by scientists at Fred Hutchinson Cancer Research Center. This finding has significant implications for developing new w ... ...
|
 INFECTIOUS DISEASE: Modified adenovirus malaria vaccine works a treat in mice Malaria kills more than 1 million individuals each year. Despite intensive research, there is still no malaria vaccine approved for use. A team of researchers, led by Moriy ... ...
|
A new IFPMA study(1), announced at the "Options for the Control of Influenza VII" conference in Hong Kong, shows that global vaccine coverage remains uneven and low overall, despite total distribution of seasonal influenza vaccines nearly doubling ... ...
Cigarette smoke shuts off a key enzyme in airways that regulates the body's response to inflammation, according to findings from the University of Alabama at Birmingham published online at Science Express... ... ...
A study published in the journal Science shows how our bodies try to minimise potential 'collateral damage' caused by our immune system when fighting infection. The research may also provide new clues to why cigarette smoke is a significant risk fa ... ...
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH), for ... ...